Testing effectiveness (Phase 2)Study completedNCT02741323
What this trial is testing
Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients
Who this might be right for
HIV InfectionsKidney Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 97